Yuma T. Ortiz

Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity

Yonghan He, Xuan Zhang, Jianhui Chang et al. · Nature Communications · 2020 · 257 citations · Full text

Medicine, Molecular Medicine, Pharmacology +13

DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas

Yonghan He, Raphael Koch, Vivekananda Budamagunta et al. · Journal of Hematology & Oncology · 2020 · 131 citations · Full text

Medicine, Cancer Biology, Oncology +14

Inhibition of USP7 activity selectively eliminates senescent cells in part via restoration of p53 activity

Yonghan He, Wen Li, Dongwen Lv et al. · Aging Cell · 2020 · 113 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Brain angiotensin type-1 and type-2 receptors: cellular locations under normal and hypertensive conditions

Colin Sumners, Amy R. Alleyne, Vermalí Rodríguez et al. · Hypertension Research · 2019 · 47 citations · Full text

Life Sciences, Neuroscience, Physiology +13

Evaluation of the terpenes β-caryophyllene, α-terpineol, and γ-terpinene in the mouse chronic constriction injury model of neuropathic pain: possible cannabinoid receptor involvement

Joshua A. Bilbrey, Yuma T. Ortiz, Jasmine S. Felix et al. · Psychopharmacology · 2021 · 36 citations

Medicine, Neuroscience, Pharmacology +13